Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16.
Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Stokkers P, Van Deventer SJ, Mirza M, Raedler A, Kruis W, Meckler U, Theuer D, Herrmann T, Gionchetti P, Lee J, Mathew C, Lennard-Jones J. Curran ME, et al. Among authors: kruis w. Gastroenterology. 1998 Nov;115(5):1066-71. doi: 10.1016/s0016-5085(98)70075-7. Gastroenterology. 1998. PMID: 9797359
[Biosimilars in inflammatory bowel disease].
Siegmund B, Atreya R, Bokemeyer B, Kruis W, Mudter J, Sander C, Schreiber S, Reindl W, Zeissig S, Kucharzik T. Siegmund B, et al. Among authors: kruis w. Z Gastroenterol. 2016 Nov;54(11):1217-1222. doi: 10.1055/s-0042-117648. Epub 2016 Oct 6. Z Gastroenterol. 2016. PMID: 27711946 Review. German.
[Ulcerative colitis. Maintenance therapy].
Kruis W, Schreiber S. Kruis W, et al. Z Gastroenterol. 2004 Sep;42(9):1011-4. doi: 10.1055/s-2004-813494. Z Gastroenterol. 2004. PMID: 15455275 German. No abstract available.
[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease].
Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Fölsch UR, Herrlinger K, Höhne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W, Matthes H, Moser G, Mundt S, Pox C, Reinshagen M, Reissmann A, Riemann J, Rogler G, Schmiegel W, Schölmerich J, Schreiber S, Schwandner O, Selbmann HK, Stange EF, Utzig M, Wittekind C. Hoffmann JC, et al. Among authors: kruis w. Z Gastroenterol. 2004 Sep;42(9):979-83. doi: 10.1055/s-2004-813510. Z Gastroenterol. 2004. PMID: 15455267 Review. German. No abstract available.
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.
Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ, Sasson AN, Agrawal M, Tiong JHT, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng SC, Rubin DT, Colombel JF, Gearry R; International Organization for Study of Inflammatory Bowel Diseases. Ananthakrishnan AN, et al. Among authors: kruis w. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):666-678. doi: 10.1016/S2468-1253(22)00021-8. Epub 2022 Apr 27. Lancet Gastroenterol Hepatol. 2022. PMID: 35487235 Review.
[Current position on Vedolizumab for ulcerative colitis and Crohn's disease].
Schreiber S, Dignass AU, Hartmann H, Kruis W, Rogler G, Siegmund B, Stallmach A, Witte C, Bokemeyer B. Schreiber S, et al. Among authors: kruis w. Z Gastroenterol. 2015 Jun;53(6):591-602. doi: 10.1055/s-0034-1399400. Epub 2015 May 27. Z Gastroenterol. 2015. PMID: 26016456 Free article. Review. German.
283 results